FDA Inspection 1049129 — Sirio Pharma Co., Ltd.
The FDA completed an inspection of Sirio Pharma Co., Ltd. on Apr 13, 2018 in Shantou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 13, 2018
- Fiscal Year
- 2018
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Shantou (China)